GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (NAS:VALN) » Definitions » Volatility

VALN (Valneva SE) Volatility : 51.39% (As of Dec. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Valneva SE Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2024-12-13), Valneva SE's Volatility is 51.39%.


Competitive Comparison of Valneva SE's Volatility

For the Biotechnology subindustry, Valneva SE's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE's Volatility Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Volatility distribution charts can be found below:

* The bar in red indicates where Valneva SE's Volatility falls into.



Valneva SE  (NAS:VALN) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valneva SE  (NAS:VALN) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Valneva SE Volatility Related Terms

Thank you for viewing the detailed overview of Valneva SE's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE Business Description

Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE Headlines

From GuruFocus

Q1 2024 Valneva SE Earnings Call Transcript

By GuruFocus Research 05-08-2024

Half Year 2021 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Valneva SE Analyst Call Transcript

By GuruFocus Research 02-09-2024

Q3 2024 Valneva SE Earnings Call Transcript

By GuruFocus News 11-08-2024

Q3 2022 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q1 2022 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q3 2020 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Full Year 2023 Valneva SE Earnings Call Transcript

By GuruFocus Research 03-21-2024

Half Year 2020 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024